-+ 0.00%
-+ 0.00%
-+ 0.00%

Sunshine Biopharma director Andrew Keller declines to seek board reelection

PUBT·08/28/2026 20:06:14
Listen to the news
Sunshine Biopharma director Andrew Keller declines to seek board reelection
  • Sunshine Biopharma director Andrew Keller will not seek re-election when his term ends at the next annual shareholder meeting.
  • Keller notified the company of his decision on Aug. 25, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006777), on August 28, 2026, and is solely responsible for the information contained therein.